1154PA phase I study of MEDI1873, a novel GITR agonist, in advanced solid tumors. (23rd October 2018) - Denlinger, C S; Infante, J R; Aljumaily, R; Naing, A; Chintakuntlawar, A; Rizvi, N A; Ross, H; Gordon, M; Kumar, R; Ma, M; Yan, L; Vicini, P; et al.